Your browser doesn't support javascript.
loading
Communication in the context of glioblastoma treatment: A qualitative study of what matters most to patients, caregivers and health care professionals.
Boele, Florien W; Butler, Sean; Nicklin, Emma; Bulbeck, Helen; Pointon, Lucy; Short, Susan C; Murray, Louise.
Afiliação
  • Boele FW; Leeds Institute of Medical Research, St James's Hospital, University of Leeds, Leeds, UK.
  • Butler S; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Nicklin E; Leeds Institute of Medical Research, St James's Hospital, University of Leeds, Leeds, UK.
  • Bulbeck H; Leeds Institute of Medical Research, St James's Hospital, University of Leeds, Leeds, UK.
  • Pointon L; Brainstrust - The Brain Cancer People, Leeds, UK.
  • Short SC; Leeds Institute of Medical Research, School of Psychology, University of Leeds, Leeds, UK.
  • Murray L; Leeds Institute of Medical Research, St James's Hospital, University of Leeds, Leeds, UK.
Palliat Med ; 37(6): 834-843, 2023 06.
Article em En | MEDLINE | ID: mdl-36734532
BACKGROUND: Patients with glioblastoma have a poor prognosis and treatment is palliative in nature from diagnosis. It is therefore critical that the benefits and burdens of treatments are clearly discussed with patients and caregivers. AIM: To explore experiences and preferences around glioblastoma treatment communication in patients, family caregivers and healthcare professionals. DESIGN: Qualitative design. A thematic analysis of semi-structured interviews. SETTING/PARTICIPANTS: A total of 15 adult patients with glioblastoma, 13 caregivers and 5 healthcare professionals were recruited from Leeds Teaching Hospitals NHS Trust. RESULTS: Four themes were identified: (1) Communication practice and preferences. Risks and side-effects of anti-tumour treatments were explained clearly, with information layered and repeated. Treatment was often understood to be 'the only option'. Understanding the impact of side-effects could be enhanced, alongside information about support services. (2) What matters most. Patients/caregivers valued being well-supported by a trusted treatment team, feeling involved, having control and quality of life. Healthcare professionals similarly highlighted trust, maintaining independence and emotional support as key. (3) Decision-making. With limited treatment options, trust and control are crucial in decision-making. Patients ultimately prefer to follow healthcare professional advice but want to be involved, consider alternatives and voice what matters to them. (4) Impact of COVID-19. During the pandemic, greater efforts to maintain good communication were necessary. Negative impacts of COVID-19 were limited, caregivers appeared most disadvantaged by pandemic-related restrictions. CONCLUSIONS: In glioblastoma treatment communication, where prognosis is poor and treatmentwill not result in cure, building trusting relationships, maintaining a sense of control and being well-informed are identified as critical.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article